iTeos Therapeutics, Inc. (ITOS) Tops Q3 EPS by 12c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q3 EPS of ($1.05), $0.12 better than the analyst estimate of ($1.17).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• J Capital Research cautious on Microchip: 'riding high on AI hype but looks weak'
• BlackBerry gains bullish backing as Stifel initiates coverage
• Micron Technology (MU) call put ratio 1.3 calls to 1 put into quarter results